News About: Goverment
KFDA announced drug items for efficacy reviews in 2001.
The KFDA announced on Jan. 27 that in 2001 the drug efficacy review would be conducted for 1,359 products including 10 different therapeutic categories according to Article 26, para 3 and Article 34 para 4 of the Phar...
Profile of Prof. Huh, the 2nd KFDA head.
On Jan. 25 Prof. Huh was suddenly nominated to the head of KFDA succeeding Dr. Park who arrested and resigned on Jan. 23.
It was absolutely no anticipated for him to be nominated as the head of KFDA, Prof. Huh said...
New KFDA head nominated to Prof. Huh Keun.
As Dr. Park Jong-se the head of KFDA was arrested on Jan. 23 in charge of bribery, and his resign was accepted, Prof. Huh Keun, the former Dean of Yungnam Univ. College of Pharmacy succeeded his position.
Seoul dis...
KFDA intensifies quality of imported drugs before market release.
The KFDA finally established "The basic plan for drug quality control in 1999" and directed it to the regional offices for the purpose of reinforcing the post administrative control on the imported drugs and cosmetics...
MOHW announced revised bill of drug classification standard.
The current provision allows only the manufacturer to change the drug classification from the professional to the general or vice versa. However, in future the pharmaceutical or medical organization are qualified to...
1999 perspective in drug industry: Drug revaluation and PMS
The new drug revaluation system implemented from 1995 seems to be substantially eased and converted to the PMS (Post marketing surveillance) after strengthening the revaluation and the monitoring of drug adverse react...
1999 perspective in drug industry: Enactment of consolidated narcotic law
In line with deregulation reforms the current narcotic law, the psychotropic drug control law and the marijuana control law will be consolidated into "The narcotics and the like control law", eliminating unnecessary r...
1999 perspective in drug industry: Toxicity test standards.
The KFDA, the National Institute of Toxicology revised the toxicity test standards for drug etc. and announced on Dec. 16 in order to meet an appropriate safety evaluation of drugs and other chemical substances in lin...
1999 perspective in drug industry: Bioequivalency test standards.
The KFDA announced the revised provisions concerning the new standards for bioequivalent test containing the extension of qualified institutes of test to all medical institutes and the increased number of test examine...
1999 perspective in drug industry: Revised Medical Affairs Law.
The government prepared the revised draft of the Medical Affairs Law in line with the deregulation and reform plans for the purpose of enhancing efficiency of the medical service for people, and presented it to the He...
